CLINICAL CAPSULES - SEMAGLUTIDE BECOMES THE FIRST ORAL GLP-1 APPROVED FOR WEIGHT LOSS

Course overview

IN THIS PODCAST, ASSOCIATE EDITOR AND CLINICAL PHARMACIST VICKIE DANAHER, PHARMD, BREAKS DOWN EVERYTHING HEALTHCARE PROFESSIONALS NEED TO KNOW ABOUT ORAL SEMAGLUTIDE FOR WEIGHT LOSS. SHE DISCUSSES HOW IT COMPARES TO INJECTABLE GLP-1 AGONISTS AND OTHER MEDS FOR OBESITY, ALONG WITH PRACTICAL GUIDANCE ON DOSING, ADMINISTRATION, AND WHEN SWITCHING FORMULATIONS MAKES SENSE.